
Global Regenerative Academy Appoints Prof. Dr. Nesrin Erçelen as Director of Regulatory Affairs
- October 28, 2024
- Miami, FL
The Global Regenerative Academy (GRA) is excited to announce the appointment of Prof. Dr. Nesrin Erçelen as the new Director of Regulatory Affairs. Dr. Erçelen brings years of experience in regulatory science and clinical research, making her an important addition to the GRA team. In this new role, she will oversee the creation and enforcement of guidelines that ensure the safety and effectiveness of regenerative therapies.
Her work will be crucial in developing clear, evidence-based regulatory frameworks that help advance GRA’s mission while maintaining patient safety and clinical integrity. As regenerative medicine continues to grow, having strong regulatory standards is more important than ever to ensure the highest level of care in fields like orthopedics, gynecology, urology, neurology, and more.
Dr. Dzihan Abazovic, President of GRA, said:
“We are delighted to have Dr. Erçelen on board. Her expertise will help us ensure that all our therapies are developed with the highest standards of safety and compliance. Regulatory oversight is critical to advancing regenerative medicine and making sure patients benefit from the latest innovations in a safe and controlled way.”
Dr. Erçelen’s appointment comes at a key moment, as GRA works to build global guidelines for regenerative therapies that are independent of industry influence. Her role will ensure that these therapies meet international standards and can be safely applied in healthcare systems around the world.
Prof. Dr. Nesrin Erçelen commented on her new role:
“I’m honored to join the Global Regenerative Academy and to be part of such important work. Strong regulatory frameworks are essential for the safe use of regenerative medicine, especially as we move into areas like cell therapies. My goal is to help GRA continue to set the highest standards in this rapidly advancing field, ensuring that these treatments are safe, effective, and widely accessible.”
With the rapid growth of regenerative medicine, having clear regulations in place will ensure that the therapies GRA develops are reliable and beneficial for patients. Dr. Erçelen’s role will be key in ensuring these standards are met as GRA continues to innovate in the field.
About the Global Regenerative Academy (GRA)
Founded in 2019, GRA is a Miami-based, non-profit organization focused on advancing regenerative medicine. GRA brings together leading experts from around the world to create evidence-based guidelines for the safe and effective use of regenerative therapies. Independent from industry influence, GRA’s mission is to improve patient care by developing innovative, non-invasive treatments.
For more information about the Global Regenerative Congress or media inquiries, please contact: